跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOMETASONA FUROATO ALTER GENERICOS 50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MOMETASONA FUROATO ALTER GENERICOS 50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL
Approved
STANDARD
MOMETASONA FUROATO ALTER GENERICOS 50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL
Laboratorios Alter S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 19, 2022
Approval ID
62fe91b96dad8832
Company
Laboratorios Alter S.A.
Type
Standard
Approval Details
Approval Id
62fe91b96dad8832
Drug Cima Aemps Name
MOMETASONA FUROATO ALTER GENERICOS 50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL
Register Number
87986
Holder Company Name
Laboratorios Alter S.A.
Marketing Company Name
Laboratorios Alter S.A.
Authorization Date
2022-07-19
Dosage Form
SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose
50 microgramos/pulsacion
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Alter S.A.
Active Ingredients
MOMETASONA FUROATO MONOHIDRATO
0,522 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 19, 2022
Approval ID
62fe91b96dad8832
Type
Standard
Back to CIMA-AEMPS Approvals